The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: PBM

Expansion and Diversification Strategies in the Pharmaceutical Industry: Part 12 of Valuation and Other Biotech Mysteries

[Ed. This is the twelfth part in Wayne's series. You can access the whole thing by clicking here. Please leave comments or questions on the blog and Wayne will address them in future posts in this series.]

Brand, human prescription drugs is the core business of the pharmaceutical industry. Risk can be diversified and potential reward can be increased by having drugs in multiple therapeutic areas. Expansion and diversification could also involve other types of drug products and healthcare activities. The best current example of healthcare diversification is Johnson & Johnson. If you look at the longer term stock chart (NYSE:JNJ), you will see that the share price continued to climb from 1999 to 2005 and has since been in a volatile trading range.

This post will look at expansion and diversification into generics, vaccines, consumer products, diagnostics, medical devices, animal health and pharmacy benefits management. Read more of this post

Follow

Get every new post delivered to your Inbox.

Join 130 other followers